E-LIB Suche - Ergebnisse für: Moreno, Carol

1

Ibrutinib followed by ofatumumab consolidation in previousl..:

Abrisqueta, Pau ; González-Barca, Eva ; Ferrà, Christelle...
eClinicalMedicine. 73 (2024) - p. 102642 , 2024

Link: https://doi.org/10.1016/..

2

P1517: HUMORAL AND CELLULAR IMMUNE RESPONSES TO SARS-COV-2 ..:

Campanella, Alessandro ; Capasso, Antonella ; Taccetti, Caterina...
HemaSphere. 7 (2023) S3 - p. e483427a , 2023

Link: https://doi.org/10.1097/..

3

POSTER: CLL-194 Ibrutinib for Treatment of Relapsed-Refract..:

Burger, Jan ; Ghia, Paolo ; Munir, Talha...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S173 , 2023

Link: https://doi.org/10.1016/..

4

P617: FIXED-DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST-..:

Ghia, Paolo ; Allan, John ; Siddiqi, Tanya...
HemaSphere. 7 (2023) S3 - p. e2822842 , 2023

Link: https://doi.org/10.1097/..

5

PB2699: CONSENSUS FROM AN EXPERT PANEL ON THE CURRENT MANAG..:

Boqué, Concepción ; Sánchez-Ramón, Silvia ; Cordoba, Raul..
HemaSphere. 7 (2023) S3 - p. e351524a , 2023

Link: https://doi.org/10.1097/..

6

PB1923: NON-HEMATOLOGIC AUTOIMMUNE DISORDERS IN CLL: PREVAL..:

De Tomás, Miguel Argüello ; Albiol, Nil ; Mora, Alba...
HemaSphere. 7 (2023) S3 - p. e979440d , 2023

Link: https://doi.org/10.1097/..

7

Fixed-duration ibrutinib–venetoclax versus chlorambucil–obi..:

Niemann, Carsten U ; Munir, Talha ; Moreno, Carol...
The Lancet Oncology. 24 (2023) 12 - p. 1423-1433 , 2023

Link: https://doi.org/10.1016/..

8

P620: GENETIC ALTERATIONS AND OUTCOMES WITH FIXED-DURATION ..:

Kater, Arnon ; Hodkinson, Brandon ; Moreno, Carol...
HemaSphere. 7 (2023) S3 - p. e56748d2 , 2023

Link: https://doi.org/10.1097/..

9

POSTER: CLL-584 Genomic Alterations and Outcomes With Fixed..:

Kater, Arnon ; Hodkinson, Brendan ; Moreno, Carol...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S174 , 2023

Link: https://doi.org/10.1016/..

10

P644: IBRUTINIB DOSE MODIFICATIONS FOR MANAGEMENT OF CARDIA..:

Stephens, Deborah ; R. Brown, Jennifer ; MA, Shuo...
HemaSphere. 7 (2023) S3 - p. e4171997 , 2023

Link: https://doi.org/10.1097/..

11

Current Approach in the Management of Secondary Immunodefic..:

Boqué, Concepción ; Sánchez-Ramón, Silvia ; Córdoba, Raúl..
Journal of Clinical Medicine. 12 (2023) 19 - p. 6356 , 2023

Link: https://doi.org/10.3390/..

12

Immune restoration with ibrutinib plus venetoclax in first-..:

Moreno, Carol ; Solman, Isabelle G. ; Tam, Constantine S....
Blood Advances. 7 (2023) 18 - p. 5294-5303 , 2023

Link: https://doi.org/10.1182/..

13

Frontline Therapy in Chronic Lymphocytic Leukemia:

Arguello-Tomas, Miguel ; Albiol, Nil ; Moreno, Carol
Acta Haematologica. 147 (2023) 1 - p. 47-59 , 2023

Link: https://doi.org/10.1159/..

14

CLL-584 Genomic Alterations and Outcomes With Fixed-Duratio..:

Kater, Arnon ; Hodkinson, Brendan ; Moreno, Carol...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S329 , 2023

Link: https://doi.org/10.1016/..

15

CLL-194 Ibrutinib for Treatment of Relapsed-Refractory Chro..:

Burger, Jan ; Ghia, Paolo ; Munir, Talha...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S322-S323 , 2023

Link: https://doi.org/10.1016/..